Esther Rajavelu has an estimated net worth of $3.05 Million. This is based on reported shares across multiple companies, which include Fulcrum Therapeutics, Inc., and Spero Therapeutics, Inc..

2025 was Esther Rajavelu's most active year for acquiring shares with 3 total transactions. Esther Rajavelu's most active month to acquire stocks was the month of January. 2026 was Esther Rajavelu's most active year for disposing of shares, totalling 4 transactions. Esther Rajavelu's most active month to dispose stocks was the month of January. 2026 saw Esther Rajavelu paying a total of $0.00 for 747,000 shares, this is the most they've acquired in one year. In 2026 Esther Rajavelu cashed out on 131,599 shares for a total of $311,408.92, their largest year based on trade value.